"Kidney Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the KIDNEY.
| Descriptor ID |
D007680
|
| MeSH Number(s) |
C04.588.945.947.535 C12.758.820.750 C12.777.419.473 C13.351.937.820.535 C13.351.968.419.473
|
| Concept/Terms |
Kidney Neoplasms- Kidney Neoplasms
- Kidney Neoplasm
- Neoplasm, Kidney
- Renal Neoplasms
- Neoplasm, Renal
- Neoplasms, Renal
- Renal Neoplasm
- Neoplasms, Kidney
Cancer of Kidney- Cancer of Kidney
- Kidney Cancers
- Renal Cancer
- Cancer, Renal
- Cancers, Renal
- Renal Cancers
- Cancer of the Kidney
- Kidney Cancer
- Cancer, Kidney
- Cancers, Kidney
|
Below are MeSH descriptors whose meaning is more general than "Kidney Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Kidney Neoplasms".
This graph shows the total number of publications written about "Kidney Neoplasms" by people in this website by year, and whether "Kidney Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 8 | 1 | 9 |
| 1995 | 5 | 1 | 6 |
| 1996 | 0 | 3 | 3 |
| 1997 | 1 | 2 | 3 |
| 1998 | 4 | 0 | 4 |
| 1999 | 1 | 1 | 2 |
| 2000 | 8 | 0 | 8 |
| 2001 | 1 | 1 | 2 |
| 2002 | 4 | 1 | 5 |
| 2003 | 3 | 1 | 4 |
| 2004 | 4 | 0 | 4 |
| 2005 | 7 | 1 | 8 |
| 2006 | 4 | 1 | 5 |
| 2007 | 5 | 1 | 6 |
| 2008 | 4 | 1 | 5 |
| 2009 | 3 | 0 | 3 |
| 2010 | 8 | 0 | 8 |
| 2011 | 7 | 0 | 7 |
| 2012 | 3 | 0 | 3 |
| 2013 | 3 | 1 | 4 |
| 2014 | 3 | 0 | 3 |
| 2015 | 5 | 3 | 8 |
| 2016 | 6 | 0 | 6 |
| 2017 | 2 | 0 | 2 |
| 2018 | 6 | 0 | 6 |
| 2019 | 4 | 0 | 4 |
| 2020 | 3 | 0 | 3 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kidney Neoplasms" by people in Profiles.
-
ACR Appropriateness Criteria? Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update. J Am Coll Radiol. 2022 05; 19(5S):S156-S174.
-
Dependence of ABCB1 transporter expression and function on distinct sphingolipids generated by ceramide synthases-2 and -6 in chemoresistant renal cancer. J Biol Chem. 2022 02; 298(2):101492.
-
Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome. Pediatr Dev Pathol. 2021 Mar-Apr; 24(2):164-168.
-
PRDM16 suppresses HIF-targeted gene expression in kidney cancer. J Exp Med. 2020 06 01; 217(6).
-
Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. Cancer Genet. 2020 06; 244:40-54.
-
Defining the human kidney N-glycome in normal and cancer tissues using MALDI imaging mass spectrometry. J Mass Spectrom. 2020 Apr; 55(4):e4490.
-
Combined Qualitative and Quantitative Assessment of Low-Attenuation Renal Lesions Improves Identification of Renal Malignancy on Noncontrast Computed Tomography. J Comput Assist Tomogr. 2019 Nov/Dec; 43(6):852-856.
-
ACR Appropriateness Criteria? Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer. J Am Coll Radiol. 2019 Nov; 16(11S):S399-S416.
-
Geographic distribution and risk of upper urothelial carcinomas in Croatia, 2001-2011. BMC Cancer. 2019 Oct 15; 19(1):950.
-
Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials. J Oncol Pharm Pract. 2020 Jun; 26(4):861-865.